www.lmu.de
|
UB
|
Browse
|
Help
Advanced Search
Deutsch
Login
Create Account
Admin
Home
Browse
Help
Faculties
Research Centers
Persons
Subjects
Keimelion
Ludovico-Maximilianea
MALTE
Advanced Search
Up a level
Export as
ASCII Citation
BibTeX
Dublin Core
Dublin Core
EP3 XML
EndNote
HTML Citation
JSON
JSON_EPUB
JSON_EPUB_DOCTYPES
JSON_EPUB_FSP
JSON_EPUB_NEW
METS
Multiline CSV
Object IDs
OpenURL ContextObject
RDF+N-Triples
RDF+N3
RDF+XML
Refer
Reference Manager
RSS 1.0
RSS 2.0
Group by:
Item Type
|
Date
Jump to:
Journal article
Number of items:
4
.
Journal article
Fischer, L.
;
Mayer, A.
;
Irger, M.
;
Freysoldt, B.
;
Zimmermann, Y.
;
Hutter, G.
;
Hiddemann, W.
and
Dreyling, M.
(2017):
CDK4/6-INHIBITION BY ABEMACICLIB INDUCES POTENT EARLY G1-ARREST IN MCL CELL LINES AND SHOWS SEQUENCE-SPECIFIC INTERACTIONS WITH CYTARABINE AND IBRUTINIB.
In: Haematologica, Vol. 102: p. 575
Hutter, G.
;
Zimmermann, Y.
;
Zoellner, A.
;
Irrgang, P.
;
Arnd, J.
;
Hiddemann, W.
and
Dreyling, M.
(2016):
Mode of action of different PI3K-inhibitors in mantle cell lymphoma.
In: Haematologica, Vol. 101: p. 271
Kvint, R.
;
Zimmermann, Y.
;
Hutter, G.
;
Hiddemann, W.
and
Dreyling, M.
(2016):
High efficiency of the pan-PI3K/mTOR inhibitor, PQR-309, in MCL.
In: Oncology Research and Treatment, Vol. 39: pp. 153-154
Hutter, G.
;
Zimmermann, Y.
;
Bamopoulos, S. A.
;
Irger, M.
;
Hiddemann, W.
and
Dreyling, M.
(2016):
Synergistic effect of inhibition of multiple PI3K-isoforms due to the differential mode of action of single PI3K-isoform inhibitors in mantle cell lymphoma.
In: Oncology Research and Treatment, Vol. 39: p. 154
This list was generated on
Sun Nov 26 02:50:19 2023 CET
.